The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Serum Albumin Market Research Report 2025
Synopsis
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The global Human Serum Albumin market was valued at US$ 5109.6 million in 2023 and is anticipated to reach US$ 8367.2 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%. In terms of its product type, human serum albumin with 20-25% concentration holds the major market share with 90%, while 5% concentration accounts for a smaller share. In terms of its application, therapeutic is its top application area, accounting for 80% of the market share.
This report aims to provide a comprehensive presentation of the global market for Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum Albumin.
Report Scope
The Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The global Human Serum Albumin market was valued at US$ 5109.6 million in 2023 and is anticipated to reach US$ 8367.2 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%. In terms of its product type, human serum albumin with 20-25% concentration holds the major market share with 90%, while 5% concentration accounts for a smaller share. In terms of its application, therapeutic is its top application area, accounting for 80% of the market share.
This report aims to provide a comprehensive presentation of the global market for Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum Albumin.
Report Scope
The Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Biotest
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Segment by Type
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Serum Albumin Market Overview
1.1 Product Overview and Scope of Human Serum Albumin
1.2 Human Serum Albumin Segment by Type
1.2.1 Global Human Serum Albumin Market Value Comparison by Type (2024-2030)
1.2.2 20-25% Concentrations
1.2.3 5% Concentrations
1.3 Human Serum Albumin Segment by Application
1.3.1 Global Human Serum Albumin Market Value by Application: (2024-2030)
1.3.2 Therapeutics
1.3.3 Excipient
1.3.4 Other
1.4 Global Human Serum Albumin Market Size Estimates and Forecasts
1.4.1 Global Human Serum Albumin Revenue 2019-2030
1.4.2 Global Human Serum Albumin Sales 2019-2030
1.4.3 Global Human Serum Albumin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Serum Albumin Market Competition by Manufacturers
2.1 Global Human Serum Albumin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Serum Albumin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Serum Albumin Average Price by Manufacturers (2019-2024)
2.4 Global Human Serum Albumin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Serum Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Serum Albumin, Product Type & Application
2.7 Human Serum Albumin Market Competitive Situation and Trends
2.7.1 Human Serum Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Serum Albumin Players Market Share by Revenue
2.7.3 Global Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Serum Albumin Retrospective Market Scenario by Region
3.1 Global Human Serum Albumin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Serum Albumin Global Human Serum Albumin Sales by Region: 2019-2030
3.2.1 Global Human Serum Albumin Sales by Region: 2019-2024
3.2.2 Global Human Serum Albumin Sales by Region: 2025-2030
3.3 Global Human Serum Albumin Global Human Serum Albumin Revenue by Region: 2019-2030
3.3.1 Global Human Serum Albumin Revenue by Region: 2019-2024
3.3.2 Global Human Serum Albumin Revenue by Region: 2025-2030
3.4 North America Human Serum Albumin Market Facts & Figures by Country
3.4.1 North America Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Serum Albumin Sales by Country (2019-2030)
3.4.3 North America Human Serum Albumin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Serum Albumin Market Facts & Figures by Country
3.5.1 Europe Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Serum Albumin Sales by Country (2019-2030)
3.5.3 Europe Human Serum Albumin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Serum Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Serum Albumin Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Serum Albumin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Serum Albumin Market Facts & Figures by Country
3.7.1 Latin America Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Serum Albumin Sales by Country (2019-2030)
3.7.3 Latin America Human Serum Albumin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Serum Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Serum Albumin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Serum Albumin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Serum Albumin Sales by Type (2019-2030)
4.1.1 Global Human Serum Albumin Sales by Type (2019-2024)
4.1.2 Global Human Serum Albumin Sales by Type (2025-2030)
4.1.3 Global Human Serum Albumin Sales Market Share by Type (2019-2030)
4.2 Global Human Serum Albumin Revenue by Type (2019-2030)
4.2.1 Global Human Serum Albumin Revenue by Type (2019-2024)
4.2.2 Global Human Serum Albumin Revenue by Type (2025-2030)
4.2.3 Global Human Serum Albumin Revenue Market Share by Type (2019-2030)
4.3 Global Human Serum Albumin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Serum Albumin Sales by Application (2019-2030)
5.1.1 Global Human Serum Albumin Sales by Application (2019-2024)
5.1.2 Global Human Serum Albumin Sales by Application (2025-2030)
5.1.3 Global Human Serum Albumin Sales Market Share by Application (2019-2030)
5.2 Global Human Serum Albumin Revenue by Application (2019-2030)
5.2.1 Global Human Serum Albumin Revenue by Application (2019-2024)
5.2.2 Global Human Serum Albumin Revenue by Application (2025-2030)
5.2.3 Global Human Serum Albumin Revenue Market Share by Application (2019-2030)
5.3 Global Human Serum Albumin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Grifols
6.1.1 Grifols Corporation Information
6.1.2 Grifols Description and Business Overview
6.1.3 Grifols Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Grifols Human Serum Albumin Product Portfolio
6.1.5 Grifols Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Human Serum Albumin Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Human Serum Albumin Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Human Serum Albumin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 CBPO
6.5.1 CBPO Corporation Information
6.5.2 CBPO Description and Business Overview
6.5.3 CBPO Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CBPO Human Serum Albumin Product Portfolio
6.5.5 CBPO Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Bio Human Serum Albumin Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kedrion Human Serum Albumin Product Portfolio
6.7.5 Kedrion Recent Developments/Updates
6.8 Shanghai RAAS
6.8.1 Shanghai RAAS Corporation Information
6.8.2 Shanghai RAAS Description and Business Overview
6.8.3 Shanghai RAAS Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shanghai RAAS Human Serum Albumin Product Portfolio
6.8.5 Shanghai RAAS Recent Developments/Updates
6.9 LFB Group
6.9.1 LFB Group Corporation Information
6.9.2 LFB Group Description and Business Overview
6.9.3 LFB Group Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 LFB Group Human Serum Albumin Product Portfolio
6.9.5 LFB Group Recent Developments/Updates
6.10 Biotest
6.10.1 Biotest Corporation Information
6.10.2 Biotest Description and Business Overview
6.10.3 Biotest Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Biotest Human Serum Albumin Product Portfolio
6.10.5 Biotest Recent Developments/Updates
6.11 Tiantan Bio
6.11.1 Tiantan Bio Corporation Information
6.11.2 Tiantan Bio Human Serum Albumin Description and Business Overview
6.11.3 Tiantan Bio Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tiantan Bio Human Serum Albumin Product Portfolio
6.11.5 Tiantan Bio Recent Developments/Updates
6.12 Shuanglin Bio
6.12.1 Shuanglin Bio Corporation Information
6.12.2 Shuanglin Bio Human Serum Albumin Description and Business Overview
6.12.3 Shuanglin Bio Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shuanglin Bio Human Serum Albumin Product Portfolio
6.12.5 Shuanglin Bio Recent Developments/Updates
6.13 Boya Bio
6.13.1 Boya Bio Corporation Information
6.13.2 Boya Bio Human Serum Albumin Description and Business Overview
6.13.3 Boya Bio Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Boya Bio Human Serum Albumin Product Portfolio
6.13.5 Boya Bio Recent Developments/Updates
6.14 Yuanda Shuyang
6.14.1 Yuanda Shuyang Corporation Information
6.14.2 Yuanda Shuyang Human Serum Albumin Description and Business Overview
6.14.3 Yuanda Shuyang Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Yuanda Shuyang Human Serum Albumin Product Portfolio
6.14.5 Yuanda Shuyang Recent Developments/Updates
6.15 Weiguang Bio
6.15.1 Weiguang Bio Corporation Information
6.15.2 Weiguang Bio Human Serum Albumin Description and Business Overview
6.15.3 Weiguang Bio Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Weiguang Bio Human Serum Albumin Product Portfolio
6.15.5 Weiguang Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Serum Albumin Industry Chain Analysis
7.2 Human Serum Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Serum Albumin Production Mode & Process
7.4 Human Serum Albumin Sales and Marketing
7.4.1 Human Serum Albumin Sales Channels
7.4.2 Human Serum Albumin Distributors
7.5 Human Serum Albumin Customers
8 Human Serum Albumin Market Dynamics
8.1 Human Serum Albumin Industry Trends
8.2 Human Serum Albumin Market Drivers
8.3 Human Serum Albumin Market Challenges
8.4 Human Serum Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
